Healthcare Companies' Annual Reports & Investor Relations Material

1067 Companies

CRY

CryoLife Inc.

CryoLife is a company that specializes in the processing and distribution of human tissues for use in cardiac and vascular surgeries. The company has been in operation since 1984 and is a leader in...

CryoLife Inc. Annual Report 2019

Healthcare Medical Appliances & Equipment NYSE 501-1000

HZNP

Horizon Therapeutics Public Company

Dublin-based biotech firm, Horizon Therapeutics Public Limited Company, has made the development and commercialization of breakthrough treatments for rare, autoimmune, and severe inflammatory disea...

Horizon Therapeutics Public Company Annual Report 2021

Healthcare Drugs - Generic NASDAQ 501-1000

ETNB

89Bio

San Francisco, CA - 89bio, Inc., a clinical-stage biopharmaceutical company with a laser focus on delivering cutting-edge therapies for liver and cardio-metabolic diseases, is making waves. The com...

89Bio Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

CORT

Corcept Therapeutics

Corcept Therapeutics Incorporated, a California-based company, has been making waves in the drug discovery and development industry. The firm specializes in curing severe metabolic, oncologic, endo...

Corcept Therapeutics Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

TLGT

Teligent, Inc.

Teligent is a company focused on the production and distribution of specialty generic prescription drugs. Their goal is to become a major player in this market and provide innovative and cost-effec...

Teligent, Inc. Annual Report 2020

Healthcare Drug Manufacturers - Other NASDAQ 201-500

POAI

Predictive Oncology

Predictive Oncology Inc., a US-based firm, is leveraging artificial intelligence (AI) to develop cancer therapies. The knowledge-driven company operates through four segments including Helomics, zP...

Predictive Oncology Annual Report 2023

Healthcare Medical Instruments & Supplies NASDAQ 11-50

IBIO

iBio

iBio, Inc., a Texas-based biotechnology company, is making strides in the development and manufacturing of biopharmaceuticals as well as vaccine and therapeutic candidates for a variety of diseases...

iBio Annual Report 2023

Healthcare Biotechnology NYSE 11-50

ZYME

Zymeworks

Zymeworks, a Vancouver-based clinical-stage biopharmaceutical company, has made significant progress in the development and commercialization of biotherapeutics for cancer treatment. The company's ...

Zymeworks Annual Report 2023

Healthcare Biotechnology NYSE 201-500

PTN

Palatin

Palatin Technologies Inc. is a distinguished biopharmaceutical company that specializes in the development of targeted receptor-specific therapeutics aimed at treating numerous diseases within the ...

Palatin Annual Report 2023

Healthcare Diagnostic Substances AMEX 51-200

MRK

Merck & Co

Merck & Co., Inc., a global healthcare company, has been operating through two major segments, Pharmaceutical and Animal Health. The Pharmaceutical segment provides a wide range of human health pha...

Merck & Co Annual Report 2023

Healthcare Drug Manufacturers - Major NYSE 10,000+

NATR

Nature's Sunshine Products

Natural health and wellness company, Nature's Sunshine Products, Inc., has established itself as a key player in the nutritional and personal care product market, operating across Asia, Europe, Nor...

Nature's Sunshine Products Annual Report 2023

Healthcare Drug Related Products NASDAQ 1001-5000

KNSA

Kiniksa Pharmaceuticals, Ltd.

Hamilton-based biopharmaceutical firm Kiniksa Pharmaceuticals is dedicated to finding, acquiring, developing and distributing therapeutic drugs aimed at treating patients suffering from debilitatin...

Kiniksa Pharmaceuticals, Ltd. Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

CRVS

Corvus Pharmaceuticals

Corvus Pharmaceuticals, a biopharmaceutical company specializing in clinical stage immuno-oncology therapies, has announced its focus on the development and commercialization of Mupadolimab (CPI-00...

Corvus Pharmaceuticals Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

RIGL

Rigel Pharmaceuticals

Biotechnology firm Rigel Pharmaceuticals, Inc. is focused on developing and delivering innovative therapies that improve the quality of life for individuals suffering from hematologic disorders and...

Rigel Pharmaceuticals Annual Report 2023

Healthcare Drug Manufacturers - Major NASDAQ 51-200

CYC

Cyclopharm Limited

Cyclopharm Limited is an Australian company that develops, manufactures and sells medical equipment and radiopharmaceuticals worldwide. The company’s services are used primarily in the detection of...

Cyclopharm Limited Annual Report 2023

Healthcare ASX 11-50